What is the price target for CVX stock?
32 analysts have analysed CVX and the average price target is 198.56 USD. This implies a price increase of 5.31% is expected in the next year compared to the current price of 188.55.
NYSE:CVX • US1667641005
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHEVRON CORP (CVX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-04-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-03-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-03-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-16 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-12 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-03-02 | B of A Securities | Maintains | Buy -> Buy |
| 2026-03-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-02 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-20 | JP Morgan | Reiterate | Overweight |
| 2026-01-14 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-06 | Freedom Capital Markets | Downgrade | Hold -> Sell |
| 2026-01-05 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2026-01-05 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-12 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-11 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-01 | HSBC | Upgrade | Hold -> Buy |
| 2025-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 196.913B -16.46% | 193.414B -1.78% | 184.432B -4.64% | 201.661B 9.34% | 202.868B 0.60% | 203.653B 0.39% | 180.197B -11.52% | N/A | |
| EBITDA YoY % growth | 42.46B -27.07% | 41.961B -1.18% | 38.281B -8.77% | 44.959B 17.44% | 51.786B 15.18% | 54.334B 4.92% | 53.816B -0.95% | 57.744B 7.30% | |
| EBIT YoY % growth | 25.134B -40.01% | 24.679B -1.81% | 18.149B -26.46% | 21.742B 19.80% | 25.71B 18.25% | 29.356B 14.18% | 33.964B 15.70% | 35.565B 4.71% | |
| Operating Margin | 12.76% | 12.76% | 9.84% | 10.78% | 12.67% | 14.41% | 18.85% | N/A | |
| EPS YoY % growth | 13.13 -30.27% | 10.05 -23.46% | 7.32 -27.16% | 6.72 -8.16% | 9.19 36.68% | 10.90 18.66% | 12.95 18.78% | 14.51 12.05% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.81 -17.19% | 2.21 24.75% | 2.16 16.91% | 2.18 43.19% | 2.24 23.93% | 2.31 4.39% | 2.48 14.61% | 2.42 10.99% | 3.14 40.54% | 3.22 39.77% | 3.65 47.23% | 3.38 39.92% |
| Revenue Q2Q % growth | 49.992B 5.00% | 49.254B 9.89% | 49.364B -0.73% | 50.03B 6.74% | 49.764B -0.46% | 50.072B 1.66% | 50.923B 3.16% | 49.537B -0.99% | 50.896B 2.27% | 50.305B 0.47% | 50.899B -0.05% | 49.074B -0.93% |
| EBITDA Q2Q % growth | 11.776B 30.27% | 13.28B 7.34% | 13.315B -30.14% | 13.153B -46.34% | 12.966B 10.11% | 13.361B 0.61% | 14.087B 5.80% | 13.765B 4.65% | 13.3B 2.58% | 13.566B 1.53% | 14.573B 3.45% | 13.91B 1.05% |
| EBIT Q2Q % growth | 5.835B 18.67% | 5.922B 51.65% | 6.069B 26.12% | 6.165B 40.69% | 5.028B -13.83% | 4.939B -16.60% | 4.604B -24.14% | 5.109B -17.13% | 6.534B 29.95% | 5.448B 10.31% | 5.045B 9.58% | 5.382B 5.34% |
All data in USD
32 analysts have analysed CVX and the average price target is 198.56 USD. This implies a price increase of 5.31% is expected in the next year compared to the current price of 188.55.
CHEVRON CORP (CVX) will report earnings on 2026-05-01, before the market open.
The consensus EPS estimate for the next earnings of CHEVRON CORP (CVX) is 1.81 USD and the consensus revenue estimate is 49.99B USD.
The number of analysts covering CHEVRON CORP (CVX) is 32.